Zhenghao Shi

Smad3 gene C-terminal phosphorylation site mutation exacerbates CCl4-induced hepatic fibrogenesis by promoting pSmad2L/C-mediated signaling transduction

Wenjing Xu, Chong Zhang, Yan Yang, 2021, Naunyn-Schmiedeberg's Archives of Pharmacology.

A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance

Xia Li, Guan-Jun Yang, Zhenghao Shi, 2022, Frontiers in Pharmacology.

Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.

Wenjing Xu, Chong Zhang, Yan Yang, 2021, Journal of ethnopharmacology.

Salvianolic acid B exerts an anti-hepatocellular carcinoma effect by regulating the Hippo/YAP pathway and promoting pSmad3L to pSmad3C simultaneously.

Chunxia Huang, Wenjing Xu, Xinmei Yu, 2022, European journal of pharmacology.